Becton Dickinson (BDX)Officer sold ~$189K

~$189K

Approx. value · 787 sh @ $240.00

15K

Holds after · shares reported

Traded

Jan 21, 2025

Filed

Jan 22, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Dec 5, 2024InsiderOfficer sold ~$330K of BDX shares in the open market
2. Dec 6, 2024Insider · 2 peopleInsiders: 2 sales (~$1.2M)
3. Dec 9, 2024InsiderOfficer sold ~$140K of BDX shares in the open market
4. Dec 19, 2024InsiderOfficer sold ~$634K of BDX shares in the open market
5. Jan 7, 2025InsiderOfficer sold ~$185K of BDX shares in the open market
6. Jan 17, 2025InsiderOfficer sold ~$141K of BDX shares in the open market
7. Jan 21, 2025 · this disclosureInsiderOfficer sold ~$189K of BDX shares in the open market

What came next

1. Jan 21, 2025InsiderOfficer sold ~$120K of BDX shares in the open market
2. Feb 10, 2025InsiderDirector purchased ~$350K of BDX shares in the open market
3. Feb 12, 2025InsiderDirector sold ~$160K of BDX shares in the open market
4. Mar 5, 2025CongressDisclosed sale of BDX — reported range $15,001 - $50,000
5. Mar 12, 2025InsiderOfficer sold ~$436K of BDX shares in the open market
6. Mar 18, 2025InsiderOfficer sold ~$106K of BDX shares in the open market
7. Apr 8, 2025CongressDisclosed sale of BDX — reported range $1,001 - $15,000
8. Apr 9, 2025InsiderOfficer sold ~$94K of BDX shares in the open market
9. May 8, 2025FDARecall: Product Name [REF]: Supply Server, CCE Enterprise SW Site License (2-5), BD Pyxis Logistics [806], BD Pyxis MedStation 4000 Main 10885403512629 [303], BD Pyxis…
10. May 8, 2025FDARecall: BD Pyxis Product Name / UDI-DI code / Catalog No. BD Pyxis" MedStation" 4000 Main / 10885403512629 / 303 BD Pyxis" MedStation" ES Tower / 10885403512674 / 352…
11. May 15, 2025FDAFDA device clearance: Bard® Temporary Pacing Electrode Catheter Needle / Cannula (Introducer)
12. May 15, 2025FDARecall: BD ChloraPrep Clear, 2% x/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA), Patient Preoperative Skin Preparation, Sterile Solution, Applica…
13. May 19, 2025FDAFDA device clearance: BD Phoenix™ Automated Microbiology System - GN Imipenem-relebactam (0.0625/4 - 16/4 µg/mL)
14. May 20, 2025FDARecall: BD BACTEC MGIT 960 PZA Kit. IVD qualitative procedure for susceptibility testing of Mycobacterium tuberculosis, from culture to pyrazinamide (PZA).
15. May 21, 2025FDARecall: REF: 381434 BD Insyte Autoguard Shielded IV Catheter, 20 GA x 1.16 in (1.1 x 30 mm) 60 mL/min, STERILEEO, RxOnly
16. May 21, 2025FDARecall: REF: 381923 BD Insyte Autoguard Winged Shielded IV Catheter, 22 GA x 1.00 in (0.9 x 25 mm) 35 mL/min, STERILEEO, RxOnly
17. May 21, 2025FDARecall: REF: 382544 BD Insyte Autoguard Shielded IV Catheter, 18 GA x 1.16 in (1.3 x 30 mm) 95 mL/min, STERILEEO, RxOnly
18. May 21, 2025FDARecall: REF: 381433, BD Insyte Autoguard Shielded IV Catheter, 20GA x 1.00 in (1.1x25 mm) 65 mL/min, STERILEEO, RxOnly
19. May 21, 2025FDARecall: REF: 381423, BD Insyte Autoguard, Shielded IV Catheter, 22GA X 1.00 IN (0.9 X 25 MM) 35mL/min, STERILEEO, RxONLY
20. May 21, 2025FDARecall: REF: 382944, BD Insyte Autoguard BC Pro Winged Shielded IV Catheter, 18 GA x 1.16 in (1.3 x 30 mm) 95 mL/min, STERILEEO, RxOnly

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Becton Dickinson

For Becton Dickinson, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 28 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BDX page.

Other recent filings by Shana Carol Neal, EVP and Chief People Officer

• SEC Form 4 at Becton Dickinson (BDX)Jan 10, 2025
• SEC Form 4 at Becton Dickinson (BDX)Dec 11, 2024

The full history of Shana Carol Neal, EVP and Chief People Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Becton Dickinson

• SEC Form 4Sep 30, 2026
• SEC Form 144Sep 28, 2026
• SEC Form 4Aug 27, 2026
• SEC Form 13F-HRAug 18, 2026
• SEC Form 4Aug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its BDX page.